Edesa Biotech
Latest round
- Series A
Last raised
- Aug 2017
Total raised
- $5.6M
Investors
- 3
About Edesa Biotech
Founded in 2015, Edesa Biotech Inc. specializes in creating therapeutic solutions for immuno-inflammatory conditions. The company was established following a merger with Stellar Biotechnologies, Inc. in June 2019, which now operates under the Edesa name. Par Nijhawan serves as both the founder and CEO.Edesa Biotech, Inc. specializes in developing monoclonal antibody candidates designed as host-directed therapeutics for immuno-inflammatory diseases. Their primary focus targets immune dysregulation associated with conditions such as Acute Respiratory Distress Syndrome (ARDS).Edesa Biotech generates revenue primarily from partnerships and collaborations related to its therapeutic development programs. These engagements include licensing agreements, research collaborations, and clinical trial partnerships with biopharmaceutical firms and research institutions.00 mn to advance its pipeline of monoclonal antibody therapeutic candidates and expand into new markets. The company is strategically targeting growth in North America and select international markets by 2023. This expansion is supported by the recent merger with Stellar Biotechnologies, which allows for enhanced operational capabilities and increased market presence. Edesa is also focused on launching new products designed to address unmet medical needs in the immuno-inflammatory space.
Who invested in Edesa Biotech
3 investors across 1 round
See all investors in Edesa Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 27, 2017
Amount
$5.6M
Investors
Questions about Edesa Biotech
Who invested in Edesa Biotech?
Edesa Biotech has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Edesa Biotech raised?
Edesa Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Edesa Biotech last raise money?
Edesa Biotech's most recent round on record is a Series A, in Aug 2017.
What does Edesa Biotech do?
Founded in 2015, Edesa Biotech Inc.
Where is Edesa Biotech headquartered?
Edesa Biotech is headquartered in Markham, Canada.
Which VCs invest in companies like Edesa Biotech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Edesa Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Edesa Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.